Inclusion Criteria:  Patients with a confirmed diagnosis of MS or Clinically Isolated Syndrome (CIS) and Atleast one clinician confirmed probable relapse between 01/04/2020 and 30/06/2020 or 01/04/2019 and 30/06/2019  Exclusion Criteria:  Age <16 years